Lack of a good model is a major bottleneck for research about how to optimize immunotherapy efficacy while limiting toxicity, and reverse-translational approaches will be vital for testing tissue-specific combination therapy, our Dr. Kristen Pauken said at #AACR26. Learn more about her work: https://t.co/mnKofFbxEU #EndCancer